Drug intelligence / Profile preview

shenkang

Development stage
Unknown
Lead developer
Xi'an Century Shengkang Pharmaceutical
Administration
Intravenous, Rectal, Oral
01

Overview

Shenkang is a traditional Chinese medicine (TCM) used for the treatment of chronic kidney disease (CKD), available in various formulations including injection (SKI), granules (SKG), and suppositories (SKS). The formula consists of several herbs, primarily rhubarb (Rheum palmatum L.), safflower (Carthamus tinctorius L.), astragalus (Astragalus mongholicus Bunge), and red sage (Salvia miltiorrhiza Bunge). [1, 3] Its therapeutic effects in CKD are attributed to its ability to reduce renal fibrosis, inflammation, and oxidative stress. [5, 6] Mechanistically, Shenkang has been shown to inhibit the renin-angiotensin system (RAS) by blocking the Wnt/β-catenin signaling pathway. [11] It also modulates other pathways, including PI3K/Akt and MAPK. [1, 5] Active components responsible for its effects include anthraquinones like rhein and emodin, as well as hydroxysafflor yellow A, tanshinol, and astragaloside IV. [5]

Brand names
Shenkang
Other names
Shenkang InjectionShenkang GranulesShenkang suppository肾康栓
02

Targets

JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)MMP9 (Matrix metalloproteinase-9)MMP2 (Matrix metalloproteinase-2)SMAD7 (Mothers against decapentaplegic homolog 7)TGFBR1PIK3CA (Phosphoinositide 3-kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on shenkang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenkang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call